ribavirin+hydroxychloroquine (BL-8020)
/ BioLineRx
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 28, 2020
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
(clinicaltrials.gov)
- P2; N=70; Not yet recruiting; Sponsor: Rutgers, The State University of New Jersey
Clinical • New P2 trial • Infectious Disease • Novel Coronavirus Disease
November 05, 2020
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
(clinicaltrials.gov)
- P2; N=70; Recruiting; Sponsor: Rutgers, The State University of New Jersey; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease
1 to 2
Of
2
Go to page
1